Importer of Controlled Substances; Notice of Application; Rhodes Technologies, 23594 [2013-09305]

Download as PDF 23594 Federal Register / Vol. 78, No. 76 / Friday, April 19, 2013 / Notices applicants for registration to import basic classes of any controlled substance in schedules I or II are, and will By email .. pubcommentcontinue to be, required to demonstrate ees.enrd@usdoj.gov. to the Deputy Assistant Administrator, By mail .... Assistant Attorney General, U.S. Office of Diversion Control, Drug DOJ—ENRD, P.O. Box 7611, Enforcement Administration, that the Washington, DC 20044–7611. requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. During the public comment period, 823(a); and 21 CFR 1301.34(b), (c), (d), the proposed Decree may be examined (e), and (f) are satisfied. and downloaded at this Justice Department Web site: https:// Dated: April 10, 2013. www.usdoj.gov/enrd/ Joseph T. Rannazzisi, Consent_Decrees.html. We will provide Deputy Assistant Administrator, Office of a paper copy of the proposed Decree Diversion Control, Drug Enforcement Administration. upon written request and payment of reproduction costs. Please mail your [FR Doc. 2013–09305 Filed 4–18–13; 8:45 am] request and payment to: BILLING CODE 4410–09–P Consent Decree Library, U.S. DOJ— ENRD, P.O. Box 7611, Washington, DEPARTMENT OF JUSTICE DC 20044–7611. Please enclose a check or money order Drug Enforcement Administration for $13.25 (.25 cents per page reproduction cost) payable to the United Importer of Controlled Substances; States Treasury. Notice of Application; Catalent CTS., Inc. Robert Brook, To submit comments: Send them to: Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. Pursuant to Title 21, of the Code of Federal Regulations 1301.34(a), this is notice that on August 6, 2012, Catalent Cts., Inc., 10245 Hickman Mills Drive, Kansas City, Missouri 64137, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances: [FR Doc. 2013–09203 Filed 4–18–13; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Rhodes Technologies Drug This is notice that on March 6, 2013, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances: Drug Schedule mstockstill on DSK4VPTVN1PROD with NOTICES Opium, Raw (9600) ...................... Poppy Straw Concentrate (9670) II II The company plans to import the listed controlled substances in order to bulk manufacture controlled substances in Active Pharmaceutical Ingredient (API) form. The company distributes the manufactured APIs in bulk to its customers. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745, all VerDate Mar<15>2010 17:11 Apr 18, 2013 Jkt 229001 I II The company plans to import a finished pharmaceutical product containing cannabis extracts in dosage form, to package for a clinical trial study. In addition, the company also plans to import an ointment for the treatment of wounds which contain trace amounts of the controlled substances normally found in poppy straw concentrate for packaging and labeling for clinical trials. Comments and requests for any hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417(2007). Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedule I or II, which fall under the authority of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at Frm 00058 Fmt 4703 Dated: April 10, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–09293 Filed 4–18–13; 8:45 am] BILLING CODE 4410–09–P Schedule Marihuana (7360) ......................... Poppy Straw Concentrate (9670) PO 00000 the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152; and must be filed no later than May 20, 2013. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745–46, all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances, Notice of Application, Almac Clinical Services, Inc., (ACSI) Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on March 5, 2013, Almac Clinical Services, Inc., (ACSI), 25 Fretz Road, Souderton, Pennsylvania 18964, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Oxycodone (9143) ........................ Hydromorphone (9150) ................ Tapentadol (9780) ........................ Fentanyl (9801) ............................ Schedule II II II II The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials. E:\FR\FM\19APN1.SGM 19APN1

Agencies

[Federal Register Volume 78, Number 76 (Friday, April 19, 2013)]
[Notices]
[Page 23594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09305]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application; Rhodes 
Technologies

    This is notice that on March 6, 2013, Rhodes Technologies, 498 
Washington Street, Coventry, Rhode Island 02816, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as an importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Opium, Raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances in 
order to bulk manufacture controlled substances in Active 
Pharmaceutical Ingredient (API) form. The company distributes the 
manufactured APIs in bulk to its customers.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (2007).
    As noted in a previous notice published in the Federal Register on 
September 23, 1975, 40 FR 43745, all applicants for registration to 
import basic classes of any controlled substance in schedules I or II 
are, and will continue to be, required to demonstrate to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, that the requirements for such registration pursuant to 
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), 
(e), and (f) are satisfied.

     Dated: April 10, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-09305 Filed 4-18-13; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.